MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10787-024-01474-3

Медицинская библиотека · Inflammopharmacology · 2024

Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study.

Rodríguez-Fernández Almudena, Visos-Varela Irene, Zapata-Cachafeiro Maruxa, Pintos-Rodríguez Samuel, García-Álvarez Rosa M, Herdeiro Teresa M, Piñeiro-Lamas María, Figueiras Adolfo, Salgado-Barreira Ángel, COVIDRUG Group

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Owing to controversy information surrounds effect of glucocorticoids on the evolution of COVID-19, we evaluate the effects of outpatient glucocorticoid use on the severity and progression of COVID-19 and risk of infection and analyse the effect of window of exposure and dose.

METHODS

We conducted a population-based case - control study, involving 4 substudies: (i) Hospitalisation; (ii) Mortality, using subjects hospitalised with a PCR + as cases and subjects without a PCR + as controls; (iii) Progression, including subjects with a PCR + (hospitalised versus non-hospitalised); and (iv) Susceptibility, with all subjects with a PCR + and subjects without a PCR + . Adjusted odds ratios (ORa) and their 95% confidence intervals (95% CI) were calculated.

RESULTS

The outpatient glucocorticoid use was associated with an increased risk of hospitalisation (aOR 1.79; 95% CI 1.56-2.05), mortality (aOR 2.30; 95% CI 1.68-3.15), progression (aOR 1.69; 95% CI 1.43-2.00) and susceptibility (aOR 1.29, 95% CI 1.19-1.41). Furthermore, the effects was observed to be greater at higher doses and the closer that drug use approached the outcome date, with an almost fourfold increase in mortality among users in the previous month (aOR 3.85; 95% CI 2.63-5.62).

CONCLUSIONS

According to the results of this real-world data study, outpatient glucocorticoid use should be considered in making decisions about intrahospital treatment.

Для цитирования: Rodríguez-Fernández Almudena, Visos-Varela Irene, Zapata-Cachafeiro Maruxa, Pintos-Rodríguez Samuel, García-Álvarez Rosa M, Herdeiro Teresa M, Piñeiro-Lamas María, Figueiras Adolfo, Salgado-Barreira Ángel, COVIDRUG Group. Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study.. Inflammopharmacology. 2024. DOI: 10.1007/s10787-024-01474-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.